Polycystic Ovarian Syndrome (PCOS) Biomarker Evaluation Study
Recruiting
Observational Study
Polycystic Ovarian Syndrome (PCOS)
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
Healthy Volunteers Welcome
You do not need to have the condition being studied to take part.
No Study Drug
Researchers observe your health over time — no experimental treatment is given.
At a Glance
- Age
- 15 – 25
- Sex
- Female
- Study type
- Observational
- Participants needed
- 380 (estimated)
- Sponsor
- University Hospital Erlangen · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
The purpose of the study is to validate recently identified biomarkers for the identification of PCOS in adolecent and young adult women.
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* Female subjects age 15-25 years
* Signed written informed consent
Exclusion Criteria:
* Less than 1 years from onset of menarche
* Use of hormonal contraceptives
* Documented ongoing pregnancy
* Major ovarian abnormalities, including subject with only one ovary, cysts and so…
Contacts